Mulakan
ReutersReuters

Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In China

RefinitivBacaan kurang dari 1 minit
1177

Sino Biopharmaceutical Ltd 1177:

  • TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINA

AsiaReutersSaham ChinaSaham Hong Kong
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini

Lebih berita dari Reuters